関連する実験動画
Updated: Sep 10, 2025
10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
12.1K
肥満 に 対し て 成功 的 に 減量 する 分子 機構 と 有望 な 治療 方法
Zsolt Szekeres1, Eszter Szabados2, Anita Pálfi2
1Department of Laboratory Medicine, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Biomedicines
|August 28, 2025
まとめ
肥満には 代謝記憶や表遺伝子などの 複雑な分子のメカニズムが関与し 体重減少を阻害します 新しい治療法は有望ですが 肥満を効果的に管理するには 長期的な有効性については さらに研究が必要です
科学分野:
- 肥満の分子メカニズム
- メタボリック障害
- 内分泌学
背景:
- 肥満は複雑な健康問題で ライフスタイル,遺伝,神経内分泌の要因を含む多因的な原因があります
- 治療にも関わらず 継続的な体重減少は大きな課題です
- 肥満の治療法の開発には 分子メカニズムを理解することが重要です
研究 の 目的:
- 体重減少を阻害する分子メカニズムに関する現在の知識をレビューする.
- 肥満管理のための新たな治療戦略を要約します.
- 肥満治療の複雑さについて 洞察を提供するためです
主な方法:
- PubMed,Scopus,Web of Scienceのデータベースに関する包括的な文献レビュー.
- ピアレビューされたオリジナルの記事,体系的なレビュー,メタ分析を含む.
- 過去10年間 (2015年-2025年) に出版された研究に焦点を当て,歴史的に重要な作品を考慮する.
主要な成果:
- 肥満は慢性疾患で 個別的で多分野的なアプローチが必要です
- 重要な分子メカニズムには,代謝記憶,表遺伝学 (DNA/ヒストン変異,マイクロRNA),脂肪組織機能障害が含まれます.
- 脂肪組織の機能障害は炎症とインスリン抵抗性を引き起こし,肥満を悪化させます.
- 脂肪細胞の種類 (白色,ベージュ,茶色) のバランスがエネルギー調節に影響します.
- 新しい医学的な介入は 減量障害を克服する可能性を 示しています
結論:
- 統合された介入 (食事,運動,薬剤療法) は肥満治療の可能性を秘めています.
- 現在の介入と新しい介入の長期的な有効性と安全性については,さらなる調査が必要である.
- 肥満の効果的な管理には 個別化された多分野戦略が不可欠です
関連する概念動画
01:24Obesity
609
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
01:30Regulation of Food Intake
350
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
350
01:24Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
01:15Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
01:23Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K